logo

For the Inventor, By the Inventor

Starnberg, Germany

Joachim Ziegenhorn

This inventor holds 40 USPTO granted patents, primarily in Biochemical Analysis. Top assignee: Boehringer Mannheim Gmbh. Active years: 1980-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joachim Ziegenhorn. Retrieved from https://idiyas.com/inventor/joachim-ziegenhorn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 40

% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 14

Forward Citations = 597(Granted Patents)


Location History:

  • Unterpfaffenhofen, DE (1980 - 1992)
  • Starnberg, DE (1980 - 1996)

Company Filing History:

goldMedal40 out of 1,164 
 
Boehringer Mannheim Gmbh
 patents

Years Active: 1980-1996

Loading Chart...
Areas of Expertise:
Fructosamine
Cholesterol
Glucose
Creatinine
Biological Activity
Enzyme Substrates
Lipids
Colorimetric
Antibody
Hemoglobin
Uric Acid
Turbidity Removal
40 patents (USPTO):Explore Patents
1. 5532172 - Process and reagent for the determination of low density lipoproteins (1996-07-02),
2. 5407836 - Process and reagent for the determination of low density lipoproteins (1995-04-18),
3. 5288606 - Reagent for specific determination of fructosamine (1994-02-22),
4. 5196314 - Process and reagent for the determination of substrates or enzyme (1993-03-23),
5. 5156947 - Process for reduction of the matrix effect in a fructosamine (1992-10-20),
6. 5149633 - Process and reagent for the specific determination of fructosamine (1992-09-22),
7. 5108913 - Process for preparing a maltoheptaose derivative (1992-04-28),
8. 5094943 - Process and reagent for the improved quantitative colorimetic (1992-03-10),
9. 5055388 - Process and reagent composition for determination of fructosamine in (1991-10-08),
10. 5013647 - Removal of interfering reducing substances with tetrazolium salts in (1991-05-07),
11. 4895799 - Process and reagent for the determination of total bilirubin (1990-01-23),
12. 4892815 - Process and reagent for the specific determination of the cholesterol of (1990-01-09),
13. 4868139 - Aqueous cholesterol standard solution and process for its preparation (1989-09-19),
14. 4851335 - Process and reagent for the specific determination of HDL cholesterol in (1989-07-25),
15. 4816393 - Nucleoside triphosphate-dependent 1-methylhydantoinase, a process for (1989-03-28),

Title: **Joachim Ziegenhorn: Innovator in Lipoprotein Determination**

Introduction

Joachim Ziegenhorn is a prominent inventor based in Starnberg, Germany, recognized for his significant contributions to the field of biochemistry. With a remarkable portfolio of 40 patents, he has made substantial advancements in diagnostic processes, particularly concerning low-density lipoproteins (LDL).

Latest Patents

Among his latest inventions, Ziegenhorn has developed a groundbreaking process and reagent for the determination of low-density lipoproteins in body fluids. This innovative method includes the addition of high-density lipoprotein (HDL) antibodies to a sample under investigation. Through this process, insoluble materials are separated, allowing for the accurate measurement of LDL or its components in the resulting supernatant. This invention not only enhances the efficiency of LDL determination but also provides a specific reagent tailored for this purpose, marking a significant advancement in clinical diagnostics.

Career Highlights

Ziegenhorn's career is notably linked with Boehringer Mannheim GmbH, where he has been instrumental in research and development. His work has greatly influenced the diagnostic tools available in the medical field, emphasizing his role as a leading inventor in his domain. His continued innovation reflects a commitment to improving health outcomes through advanced laboratory techniques.

Collaborations

Throughout his career, Ziegenhorn has collaborated with distinguished professionals such as Joachim Siedel and Albert Roder. These partnerships have fostered a collaborative environment for the exchange of ideas and enhancements in their respective projects, contributing to the successful development of innovative solutions in the field of biochemistry.

Conclusion

Joachim Ziegenhorn stands out as an exemplary inventor who has dedicated his career to enhancing the understanding and measurement of lipoproteins. His innovations have substantial implications in the field of medical diagnostics, highlighting the critical nature of his work and the enduring impact he has made in advancing health technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…